Tag Archives: AI drug discovery

March 8, 2021
Atomwise wins “Best use of AI in Health and Medicine” in 5th Annual AI Awards
In The News
Read Article
January 12, 2021
What DeepMind’s leap means for structure-based drug developers
In The News
Read Article
December 21, 2020
Atomwise, FutuRx launch new AI-powered immuno-oncology biotech
In The News

After raising $123 million this past summer to fuel its artificial-intelligence-based drug design work, Atomwise has helped launch a new company focused on uncovering treatments in immuno-oncology.

Read Article
December 18, 2020
Atomwise and FutuRx Launch A2i Therapeutics – A New Immuno-Oncology Company Funded By Leading Biopharma VCs and the Israeli Innovation Authority
In The News

A2i Therapeutics secures seed funding from FutuRx and its investors – Johnson & Johnson Innovation (JJDC, Inc.), Takeda Ventures, OrbiMed Partners, Leaps by Bayer and the Israeli Innovation Authority – to develop novel small molecule immuno-oncology agents.

Read Article
December 18, 2020
Atomwise and FutuRx Launch A2i Therapeutics – A New Immuno-Oncology Company Funded By Leading Biopharma VCs and the Israeli Innovation Authority
FeaturedPress Release

A2i Therapeutics secures seed funding from FutuRx and its investors – Johnson & Johnson Innovation (JJDC, Inc.), Takeda Ventures, OrbiMed Partners, Leaps by Bayer and the Israeli Innovation Authority – to develop novel small molecule immuno-oncology agents. SAN FRANCISCO, CA and NESS ZIONA, Israel – December  18, 2020 – Atomwise, the leader in using artificial […]

Read Article
November 30, 2020
Drug Discovery’s AI Paradigm Shift with Dr. Abraham Heifets
Broadcast
Read Article